As of October 29, 2026, Cytokinetics had a market cap of $8.785 billion, which increased by 3.32% compared to the previous trading day. Market capitalization, often referred to as market cap, represents the total value of a company's outstanding shares on the stock market and is a common measure of its overall size and valuation.
Data updated: Oct 29, 2026, 4:00 PM ET
Cytokinetics, Inc. (CYTK)
🌍 United States📈 NASDAQ🏭 Health Care🏢 Biotechnology
Note: Each point on the chart represents the market capitalization at the end of the trading day. Source: Data compiled from
EDGAR filings,
Bloomberg
and Yahoo Finance.
📈 Cytokinetics Market Cap History by Year and Month
Cytokinetics Market Cap History by Year and Month
Year / Month
Market Cap
% Change
2026
$8.785B
▲ 13.08%
$8.785B
▼ 3.95%
$9.146B
▼ 7.05%
$9.84B
▲ 2.69%
$9.582B
▼ 9.43%
$10.58B
▲ 1.54%
$10.42B
▲ 32.25%
$7.879B
▼ 2.94%
$8.118B
▲ 6.72%
$7.607B
▼ 1.54%
$7.726B
▼ 0.55%
2025
$7.769B
▲ 39.71%
$7.769B
▼ 6.73%
$8.33B
▲ 7.26%
$7.766B
▲ 15.70%
$6.712B
▲ 58.75%
$4.228B
▼ 6.09%
$4.502B
▲ 13.92%
$3.952B
▲ 6.67%
$3.705B
▼ 27.45%
$5.107B
▲ 6.60%
$4.791B
▼ 12.06%
$5.448B
▼ 6.82%
$5.847B
▲ 5.14%
2024
$5.561B
▼ 32.07%
$5.561B
▼ 9.13%
$6.12B
▲ 1.80%
$6.012B
▼ 3.42%
$6.225B
▼ 7.31%
$6.716B
▼ 3.16%
$6.935B
▲ 9.23%
$6.349B
▲ 13.11%
$5.613B
▼ 12.62%
$6.424B
▼ 12.38%
$7.332B
▼ 1.74%
$7.462B
▼ 6.03%
$7.941B
▼ 2.99%
2023
$8.186B
▲ 88.79%
$8.186B
▲ 149.35%
$3.283B
▼ 2.15%
$3.355B
▲ 18.64%
$2.828B
▼ 15.68%
$3.354B
▲ 4.81%
$3.2B
▲ 2.24%
$3.13B
▼ 13.18%
$3.605B
▲ 0.81%
$3.576B
▲ 6.27%
$3.365B
▼ 18.44%
$4.126B
▲ 2.43%
$4.028B
▼ 7.10%
2022
$4.336B
▲ 12.19%
$4.336B
▲ 7.81%
$4.022B
▼ 2.59%
$4.129B
▼ 9.89%
$4.582B
▼ 8.10%
$4.986B
▲ 37.09%
$3.637B
▲ 7.73%
$3.376B
▼ 1.20%
$3.417B
▲ 0.15%
$3.412B
▲ 8.32%
$3.15B
▲ 5.11%
$2.997B
▲ 6.47%
$2.815B
▼ 27.17%
2021
$3.865B
▲ 161.86%
$3.865B
▲ 17.12%
$3.3B
▲ 12.74%
$2.927B
▼ 2.30%
$2.996B
▲ 8.83%
$2.753B
▲ 11.41%
$2.471B
▲ 73.65%
$1.423B
▼ 9.13%
$1.566B
▼ 13.96%
$1.82B
▲ 9.38%
$1.664B
▲ 24.92%
$1.332B
▼ 4.65%
$1.397B
▼ 5.35%
2020
$1.476B
▲ 135.03%
$1.476B
▲ 24.14%
$1.189B
▲ 9.59%
$1.085B
▼ 28.99%
$1.528B
▼ 9.53%
$1.689B
▲ 10.97%
$1.522B
▲ 7.71%
$1.413B
▲ 14.69%
$1.232B
▲ 37.19%
$0.898B
▲ 28.10%
$0.701B
▼ 15.03%
$0.825B
▲ 13.32%
$0.728B
▲ 15.92%
2019
$0.628B
▲ 81.50%
$0.628B
▲ 9.79%
$0.572B
▼ 16.86%
$0.688B
▲ 2.38%
$0.672B
▼ 18.45%
$0.824B
▲ 16.38%
$0.708B
▲ 9.09%
$0.649B
▲ 8.35%
$0.599B
▲ 17.68%
$0.509B
▲ 13.62%
$0.448B
▲ 13.42%
$0.395B
▲ 2.60%
$0.385B
▲ 11.27%
2018
$0.346B
▼ 21.18%
$0.346B
▼ 19.53%
$0.43B
▲ 17.49%
$0.366B
▼ 31.97%
$0.538B
▲ 24.54%
$0.432B
▲ 7.46%
$0.402B
▼ 10.67%
$0.45B
▼ 7.79%
$0.488B
▲ 8.44%
$0.45B
▲ 15.68%
$0.389B
▼ 7.16%
$0.419B
▼ 15.52%
$0.496B
▲ 12.98%
2017
$0.439B
▼ 11.13%
$0.439B
▼ 5.18%
$0.463B
▼ 37.01%
$0.735B
▼ 5.53%
$0.778B
▼ 2.38%
$0.797B
▲ 5.70%
$0.754B
▲ 16.54%
$0.647B
▼ 6.77%
$0.694B
▼ 6.09%
$0.739B
▲ 32.44%
$0.558B
▲ 25.96%
$0.443B
▲ 4.24%
$0.425B
▼ 13.97%
2016
$0.494B
▲ 19.32%
$0.494B
▲ 1.65%
$0.486B
▲ 23.66%
$0.393B
▲ 5.65%
$0.372B
▼ 22.34%
$0.479B
▲ 8.62%
$0.441B
▲ 16.98%
$0.377B
▲ 16.72%
$0.323B
— 0.00%
$0.323B
▲ 15.77%
$0.279B
▲ 11.60%
$0.25B
▼ 18.03%
$0.305B
▼ 26.33%
2015
$0.414B
▲ 33.55%
$0.414B
▼ 9.80%
$0.459B
▲ 37.43%
$0.334B
▲ 28.96%
$0.259B
▼ 3.36%
$0.268B
▲ 8.06%
$0.248B
▼ 4.62%
$0.26B
▲ 5.26%
$0.247B
▲ 1.23%
$0.244B
▼ 7.22%
$0.263B
▼ 11.74%
$0.298B
▲ 8.76%
$0.274B
▼ 11.61%
2014
$0.31B
▲ 55.78%
$0.31B
▲ 81.29%
$0.171B
▲ 27.61%
$0.134B
▲ 3.88%
$0.129B
▼ 17.83%
$0.157B
▲ 1.29%
$0.155B
▼ 11.43%
$0.175B
▼ 4.37%
$0.183B
▲ 11.59%
$0.164B
▼ 52.19%
$0.343B
▼ 3.38%
$0.355B
▲ 49.16%
$0.238B
▲ 19.60%
2013
$0.199B
▲ 111.68%
$0.199B
▲ 4.19%
$0.191B
▲ 7.91%
$0.177B
▼ 20.63%
$0.223B
▼ 27.36%
$0.307B
▼ 15.89%
$0.365B
▲ 27.18%
$0.287B
▲ 61.24%
$0.178B
▼ 6.32%
$0.19B
▲ 13.77%
$0.167B
▲ 15.97%
$0.144B
▼ 14.29%
$0.168B
▲ 78.70%
2012
$94.01M
▲ 35.45%
$94.01M
▲ 3.12%
$91.162M
▼ 5.88%
$96.859M
▼ 12.74%
$0.111B
▲ 9.90%
$0.101B
▲ 9.65%
$92.115M
▲ 85.67%
$49.613M
▼ 30.43%
$71.318M
▼ 8.91%
$78.295M
▼ 10.86%
$87.837M
▲ 11.65%
$78.671M
▼ 0.02%
$78.687M
▲ 13.37%
2011
$69.408M
▼ 50.42%
$69.408M
▼ 5.88%
$73.746M
▼ 12.07%
$83.868M
▼ 0.85%
$84.591M
▲ 2.63%
$82.422M
▼ 9.52%
$91.098M
▲ 0.80%
$90.375M
▼ 14.74%
$0.106B
▼ 1.85%
$0.108B
▲ 8.35%
$99.681M
▼ 5.07%
$0.105B
▼ 17.32%
$0.127B
▼ 9.29%
2010
$0.14B
▼ 21.35%
$0.14B
▼ 4.11%
$0.146B
▼ 16.09%
$0.174B
▲ 2.35%
$0.17B
▲ 18.06%
$0.144B
▼ 18.64%
$0.177B
▲ 15.69%
$0.153B
▼ 19.05%
$0.189B
▼ 8.70%
$0.207B
▲ 3.50%
$0.2B
▲ 7.53%
$0.186B
▲ 0.54%
$0.185B
▲ 3.93%
2009
$0.178B
▲ 25.35%
$0.178B
▼ 5.82%
$0.189B
▼ 2.58%
$0.194B
▼ 39.75%
$0.322B
▲ 66.84%
$0.193B
▲ 7.22%
$0.18B
▲ 4.65%
$0.172B
▲ 17.81%
$0.146B
▲ 46.47%
$99.681M
▲ 9.47%
$91.055M
▲ 8.29%
$84.088M
▼ 20.67%
$0.106B
▼ 25.35%
2008
$0.142B
▼ 39.06%
$0.142B
▲ 10.94%
$0.128B
▼ 9.22%
$0.141B
▼ 39.74%
$0.234B
▼ 8.95%
$0.257B
▼ 1.53%
$0.261B
▲ 42.62%
$0.183B
▼ 7.58%
$0.198B
▲ 16.47%
$0.17B
▲ 3.66%
$0.164B
▼ 1.20%
$0.166B
▲ 1.22%
$0.164B
▼ 29.61%
2007
$0.233B
▼ 17.67%
$0.233B
▼ 2.51%
$0.239B
▼ 1.65%
$0.243B
▲ 1.25%
$0.24B
▲ 4.80%
$0.229B
▼ 2.55%
$0.235B
▼ 10.98%
$0.264B
▼ 15.38%
$0.312B
▲ 0.97%
$0.309B
▼ 5.21%
$0.326B
▼ 10.44%
$0.364B
▲ 6.43%
$0.342B
▲ 20.85%
2006
$0.283B
▲ 51.34%
$0.283B
▼ 0.70%
$0.285B
▲ 3.26%
$0.276B
▲ 16.95%
$0.236B
▼ 5.60%
$0.25B
▲ 17.37%
$0.213B
▼ 7.39%
$0.23B
▼ 9.45%
$0.254B
▼ 3.79%
$0.264B
▲ 1.54%
$0.26B
▲ 2.36%
$0.254B
▲ 19.81%
$0.212B
▲ 13.37%
2005
$0.187B
▼ 35.96%
$0.187B
▼ 23.98%
$0.246B
▲ 9.82%
$0.224B
▼ 3.86%
$0.233B
▲ 0.43%
$0.232B
▼ 9.02%
$0.255B
▲ 28.14%
$0.199B
▲ 28.39%
$0.155B
▲ 10.71%
$0.14B
▼ 25.13%
$0.187B
▼ 32.25%
$0.276B
▼ 1.08%
$0.279B
▼ 4.45%
2004
$0.292B
▼ 32.41%
$0.292B
▲ 19.67%
$0.244B
▼ 4.31%
$0.255B
▼ 32.36%
$0.377B
▲ 37.09%
$0.275B
▲ 17.02%
$0.235B
▼ 44.18%
$0.421B
▼ 4.32%
$0.44B
▲ 0.92%
$0.436B
▲ 0.93%
All market cap values reflect closing prices for the period shown.
📊 Cytokinetics Market Cap and Other Industry Peers
Below are selected companies from the Biotechnology sector / subsector: